- 详细信息
- 询价记录
- 相关实验
- 技术资料
-
- 货号:
AG-44B-0006
- 克隆性:
多克隆
"生物活性IDO1,CTLA-4,PD-1,B7-H4,LAG-3 ,Tim-3
IDO1酶&主要抑制剂
IDO1 (human) Enzyme+Inhibitor Set
AG-44B-0006
IDO1 (human) (rec.) (His) (highly active)
AG-40B-0161
MMG-0358 Potent Triazole IDO1 Inhibitor AG-CR1-3630
IC50值,mIDO1细胞检测是2nM,hIDO1细胞检测是80nM,hIDO1(pH 6.5)酶活检测是330nM,hIDO1(pH7.4)的酶活检测是71nM。体内有活性。
参考文献
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition: U.F. Roehrig, et al.; J. Med. Chem. 55, 5270 (2012)
活性免疫检测点蛋白
B7-H4 (human):Fc (human) (rec.)
CHI-HF-210B7H4
B7-H4 (mouse):Fc (mouse) (rec.)
CHI-MF-110B7H4
CTLA-4 (human):Fc (human) (rec.)
CHI-HF-210A4
CTLA-4 (human):Fc (human) (rec.) (non-lytic)
CHI-HF-220A4
CTLA-4 (human):Fc (mouse) (rec.)
CHI-HF-211A4
CTLA-4 (mouse):Fc (mouse) (rec.)
CHI-MF-110A4
CTLA-4 (mouse):Fc (mouse) (rec.) (non-lytic)
CHI-MF-120A4
PD-1 (human):Fc (human) (rec.)
CHI-HF-210PD1
PD-1 (human):Fc (human) (rec.) (non-lytic)
CHI-HF-220PD1
PD-1 (mouse):Fc (mouse) (rec.)
CHI-MF-110PD1
PD-L1/B7-H1 (human):Fc (human) (rec.)
CHI-HF-210PDL1
PD-L1/B7-H1 (human):Fc (human) (rec.) (non-lytic)
CHI-HF-220PDL1
PD-L1/B7-H1 (mouse):Fc (mouse) (rec.)
CHI-MF-110PDL1
PD-L1/B7-H1 (mouse):Fc (mouse) (rec.) (non-lytic)
CHI-MF-120PDL1
PD-L2 (human):Fc (human) (rec.)
CHI-HF-210PDL2
PD-L2 (human):Fc (human) (rec.) (non-lytic)
CHI-HF-220PDL2
PD-L2 (mouse):Fc (mouse) (rec.)
CHI-MF-110PDL2
肿瘤免疫治疗的LAG-3
功能性封闭抗体
LAG-3 (human), mAb (blocking) (17B4)
AG-20B-0012
LAG-3 (human), mAb (blocking) (17B4) (preservative free)
AG-20B-0012PF
LAG-3, mAb (blocking) (11E3)
AG-20B-0011
LAG-3, mAb (blocking) (11E3) (preservative free)
AG-20B-0011PF
生物活性蛋白
LAG-3 (human):Fc (human) (rec.)
AG-40B-0031
LAG-3 (mouse):Fc (mouse) (rec.)
AG-40B-0039
T-细胞免疫球蛋白和粘蛋白结构域
Tim-3 (human):Fc (human) (rec.)
CHI-HF-210T3
Tim-3 (mouse):Fc (mouse) (rec.)
CHI-MF-110T3
CD1d配体抗肿瘤佐剂
α-Galactosylceramide
Potent NKT Cell stimulator
强有效NKT 激活剂
AG-CN2-0013
在人类和小鼠NKT细胞里MHC-I蛋白和CD1d分子脂质结合的特异性配体。
参考文献
LIT: Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine: F. Gableh, et al.; J.
Biomed. Sci. 23, 16 (2016)
全部产品请见CD1d配体单页
"
风险提示:仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 货号:
-
该产品暂未上传技术资料
免费索取技术资料